Get the Stockscreener App
1.34
3.60%
-0.05
After Hours:
1.34
Biodesix Inc stock is traded at $1.34, with a volume of 1.25M.
It is down -3.60% in the last 24 hours and down -20.71% over the past month.
Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.
See More
Previous Close:
$1.39
Open:
$1.46
24h Volume:
1.25M
Relative Volume:
7.00
Market Cap:
$194.54M
Revenue:
$49.09M
Net Income/Loss:
$-52.15M
P/E Ratio:
-1.2182
EPS:
-1.1
Net Cash Flow:
$-45.93M
1W Performance:
-18.79%
1M Performance:
-20.71%
6M Performance:
-4.29%
1Y Performance:
-16.25%
1-Day Range:
$1.33
$1.46
1-Week Range:
$1.28
$1.7197
52-Week Range:
$1.15
$2.21
Biodesix Inc Stock (BDSX) Company Profile
Name
Biodesix Inc
Sector
Industry
Phone
303-417-0500
Address
919 WEST DILLON ROAD, LOUISVILLE
Biodesix Inc Stock (BDSX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-17-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Nov-23-20 | Initiated | BTIG Research | Buy |
| Nov-23-20 | Initiated | Canaccord Genuity | Buy |
| Nov-23-20 | Initiated | Morgan Stanley | Overweight |
| Nov-23-20 | Initiated | William Blair | Outperform |
Biodesix Inc Stock (BDSX) Latest News
Biodesix, Inc. (NASDAQ:BDSX) Q3 2024 Earnings Call Transcript - MSN
Earnings call: Biodesix sees strong growth in Q3 with $18.2M revenue - Investing.com India
Brokerages Set Biodesix, Inc. (NASDAQ:BDSX) PT at $3.06 - MarketBeat
Biodesix, Inc. (NASDAQ:BDSX) Receives Consensus Rating of “Buy” from Analysts - Defense World
Biodesix (NASDAQ:BDSX) Issues Earnings Results, Beats Expectations By $0.01 EPS - MarketBeat
Biodesix reports Q3 EPS (7c), consensus (7c) - MSN
Biodesix Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance
Biodesix Inc (BDSX) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid Operational ... - Yahoo Finance UK
Biodesix Inc (BDSX) Q3 2024 Earnings Call Highlights: Strong Rev - GuruFocus.com
Biodesix Reports Strong Q3 2024 Growth in Diagnostics - TipRanks
Biodesix trims losses but misses Wall Street sales projection - BizWest
Biodesix Announces Third Quarter 2024 Results and Highlights - GlobeNewswire
Biodesix, Inc. (BDSX) Reports Q3 Loss, Misses Revenue Estimates - Yahoo Finance
Biodesix Inc (BDSX) Q3 2024 Earnings: Revenue at $18.2M, EPS Mat - GuruFocus.com
Biodesix, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Biodesix, Inc. Reiterates Revenue Guidance for the Fiscal Year 2024-25 - Marketscreener.com
What To Expect From Biodesix Inc (BDSX) Q3 2024 Earnings - Yahoo Finance
With 47% ownership, Biodesix, Inc. (NASDAQ:BDSX) insiders have a lot riding on the company's future - Yahoo Finance
Biodesix to Participate in Three Investor Conferences in November - The Manila Times
Scotiabank Initiates Coverage of Biodesix (BDSX) with Sector Outperform Recommendation - MSN
Biodesix (BDSX) Set to Announce Quarterly Earnings on Friday - Defense World
Biodesix (BDSX) Scheduled to Post Earnings on Friday - MarketBeat
Biodesix to Report Third Quarter 2024 Financial Results on November 1, 2024 - Business Wire
Short Interest in Biodesix, Inc. (NASDAQ:BDSX) Rises By 29.3% - MarketBeat
Biodesix, Inc. (NASDAQ:BDSX) Given Average Recommendation of "Buy" by Brokerages - MarketBeat
Biodesix Announces New Data Presentation at CHEST 2024 Annual Meeting and the Launch of a Complementary Clinical Study - BioSpace
Perceptive Advisors LLC Takes $3.33 Million Position in Biodesix, Inc. (NASDAQ:BDSX) - Defense World
2,173,880 Shares in Biodesix, Inc. (NASDAQ:BDSX) Bought by Perceptive Advisors LLC - MarketBeat
Biodesix, Inc. (NASDAQ:BDSX) Short Interest Down 9.2% in September - MarketBeat
CVI Holdings LLC Makes New Investment in Biodesix, Inc. (NASDAQ:BDSX) - Defense World
Biodesix Inc (BDSX) Stock: A Year of Stock Market Ups and Downs - The InvestChronicle
Farallon Capital Management LLC Purchases New Stake in Biodesix, Inc. (NASDAQ:BDSX) - Defense World
Trading Day Triumph: Biodesix Inc (BDSX) Ends at 1.59, a -11.67 Surge/Plunge - The Dwinnex
Farallon Capital Management LLC Takes Position in Biodesix, Inc. (NASDAQ:BDSX) - MarketBeat
Does Biodesix (NASDAQ:BDSX) Have A Healthy Balance Sheet? - Simply Wall St
Biodesix Inc (BDSX) expanding its growth trajectory ahead - SETE News
Biohaven surges as genetic disease drug meets main study goal By Reuters - Investing.com
Sartorius Stedim Biotech S.A. (EPA:DIM) On An Uptrend: Could Fundamentals Be Driving The Stock? - Simply Wall St
Market Watch Highlights: Biodexa Pharmaceuticals Plc ADR (BDRX) Ends on an Downturn Note at 0.29 - The Dwinnex
Inspire Investing LLC Has $353,000 Stake in Brandywine Realty Trust (NYSE:BDN) - Defense World
Brandywine Realty Trust (BDN) Performance and Fundamentals Dashboard tells a completely different story - SETE News
BCDA’s Stochastic Averages Dip: Analyzing BioCardia Inc.’s Stock Performance - The InvestChronicle
Biodesix, Inc. (NASDAQ:BDSX) Sees Significant Decrease in Short Interest - Defense World
BD launches new prefillable syringe, expands platform capacity - Drug Delivery Business News
Biodesix (NASDAQ:BDSX) Coverage Initiated at Scotiabank - Defense World
Biodexa Pharmaceuticals Plc (NASDAQ:BDRX) Short Interest Update - Defense World
Sartorius Stedim Biotech (EPA:DIM) Shares Down 1.3% - Defense World
Despite lower earnings than five years ago, Boyd Group Services (TSE:BYD) investors are up 19% since then - Simply Wall St
Boyd Group Services Announces Q3 Cash Dividend - TipRanks
Biodesix (NASDAQ:BDSX) Now Covered by Scotiabank - MarketBeat
Biodesix initiated with an Outperform at Scotiabank - TipRanks
Biodesix Inc Stock (BDSX) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.48%
0.04%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):